Highlights

Search of Patents

Search of Patents

List of Patents

Back HER2 AS A GENOMIC PREDICTOR IN HER2+ BREAST CANCER

HER2 AS A GENOMIC PREDICTOR IN HER2+ BREAST CANCER

HER2 AS A GENOMIC PREDICTOR IN HER2+ BREAST CANCER

The present invention allows predicting the degree of efficacy of different therapies in HER2+ breast cancer patients. The method uses an in vitro marker that helps the oncologist decide the most appropriate therapy, and particularly in the possibility of avoiding chemotherapy in the early stages of this disease.

INDUSTRIAL PROPERTY RIGHTS

The technology has been filed under patent application to the European Patent Office, with priority date 07/12/2016, adn in co-ownership with the Vall d'Hebron Institute of Oncology Private Foundation, SOLTI Foundation and Hospital Clínic de barcelona. 

Quality of Life: Health Promotion and Efficient Health

CONTACT:

Antonio Llombart Cussac

Jefe del Servicio de Oncología

Hospital Arnau de Vilanova

Tel: +34963987700

E-mail:allombart1@yahoo.com

 

Area de Innovación

FISABIO

Avda. Catalunya, 21

46010 - Valencia

Tel: +34961926351

E-mail: innovacion_fisabio@gva.es

Web: www.fisabio.es